Immunic logo

Immunic Share Price (NASDAQ: IMUX)

$0.82

-0.05

(-5.75%)

Last updated on

Check the interactive Immunic Stock chart to analyse performance

Immunic stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.81
    Today's High:$0.87

    Day's Volatility :7.13%

  • 52 Weeks Low:$0.56
    52 Weeks High:$2.11

    52 Weeks Volatility :73.41%

Immunic Stock Returns

PeriodImmunic IncSector (Health Care)Index (Russel 2000)
3 Months
17.17%
3.6%
0.0%
6 Months
-29.29%
-7.7%
0.0%
1 Year
-41.41%
-12.6%
0.0%
3 Years
-81.57%
9.5%
-4.7%

Immunic Inc Key Stats

Check Immunic key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.87
Open
$0.8722
Today's High
$0.8722
Today's Low
$0.81
Market Capitalization
$80.9M
Today's Volume
$1.4M
52 Week High
$2.11
52 Week Low
$0.561001
Revenue TTM
$0.0
EBITDA
$-105.1M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-208.93%

Stock Returns calculator for Immunic Stock including INR - Dollar returns

The Immunic stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunic investment value today

Current value as on today

₹63,856

Returns

₹36,144

(-36.14%)

Returns from Immunic Stock

₹41,429 (-41.43%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Immunic Stock

51%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Immunic Stock from India on INDmoney has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immunic Inc

  • Name

    Holdings %

  • Aberdeen Group PLC

    8.36%

  • Bvf Inc

    7.76%

  • Soleus Capital Management, L.P.

    7.39%

  • Avidity Partners Management LP

    5.69%

  • Vanguard Group Inc

    4.18%

  • The Colony Group LLC

    2.62%

Analyst Recommendation on Immunic Stock

Rating
Trend

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Immunic(by analysts ranked 0 to 5 stars)

Immunic Share Price Target

What analysts predicted

Upside of 831.71%

Target:

$7.64

Current:

$0.82

Immunic share price target is $7.64, a slight Upside of 831.71% compared to current price of $0.82 as per analysts' prediction.

Immunic Stock Insights

  • Price Movement

    In the last 7 days, IMUX stock has moved down by -13.7%
  • IMUX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 115.6%
  • IMUX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 194.8%

Immunic Technicals Summary

Sell

Neutral

Buy

Immunic is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immunic Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Immunic Inc logo
-12.75%
-29.29%
-41.41%
-81.57%
-94.61%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Immunic Inc

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
Organization
Immunic
Employees
90
CEO
Dr. Daniel Vitt Ph.D.
Industry
Pharmaceuticals: Major

Key Management of Immunic Inc

NameTitle
Dr. Duane D. Nash J.D., M.B.A., M.D.
Executive Chairman
Dr. Daniel Vitt Ph.D.
CEO & Director
Mr. Jason Tardio M.B.A.
COO & President
Mr. Glenn Whaley CPA
Chief Financial Officer
Dr. Andreas Muehler M.D., Ph.D.
Chief Medical Officer
Dr. Hella Kohlhof
Chief Scientific Officer
Ms. Jessica Breu
Head of Investor Relations & Communications
Mr. Inderpal Singh
General Counsel
Mr. Patrick Walsh
Chief Business Officer
Mr. Werner Gladdines
Chief Development Officer

Important FAQs about investing in IMUX Stock from India :

What is Immunic share price today?

Immunic share price today is $0.82 as on at the close of the market. Immunic share today touched a day high of $0.87 and a low of $0.81.

What is the 52 week high and 52 week low for Immunic share?

Immunic share touched a 52 week high of $2.11 and a 52 week low of $0.56. Immunic stock price today i.e. is closed at $0.82, lower by 61.14% versus the 52 week high.

How to invest in Immunic Stock (IMUX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunic on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunic Shares that will get you 1.8293 shares as per Immunic share price of $0.82 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunic Stock (IMUX) from India?

Indian investors can start investing in Immunic (IMUX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Immunic stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Immunic share’s latest price of $0.82 as on August 30, 2025 at 1:29 am IST, you will get 12.1951 shares of Immunic. Learn more about fractional shares .

What are the returns that Immunic has given to Indian investors in the last 5 years?

Immunic stock has given -94.61% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?